Maxson, Julia E <br/><br/>
Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis.  [electronic resource] 

 -  Cancer research  Jan 2016 
 - 127-38 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-15-0817  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Base Sequence<br/>Cell Line, Tumor<br/>Drug Screening Assays, Antitumor--methods<br/>Female<br/>Genomics<br/>HEK293 Cells<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Mice<br/>Models, Molecular<br/>Point Mutation<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Transfection